Medpace at AAPS 2026 PharmSci 360
Oct 25–28, 2026 New Orleans, LA ~4k attendees Website
Medpace brings 2 presentations to AAPS 2026 PharmSci 360 in New Orleans. Medpace's program centres on bioanalytical assays for clinical samples. Its work covers an enzyme-based colour assay for sphingomyelin in human plasma, and a ligand binding assay for the recombinant enzyme heparan-N-sulfatase in cerebrospinal fluid.
| Organization | AAPS 2026 PharmSci 360 Attendance |
|---|---|
Medpace Cincinnati, OH | |
Clinical CRO whose bioanalytical labs measure drugs and biomarkers in study samples. | Poster Mon Oct 26 10:30am–11:30am Determination of Concentration of Sphingomyelin Concentration in Human Plasma K 2 EDTA using an Enzymatic Colorimetric Assay (ECA) Poster Tue Oct 27 3:30pm–4:30pm Determination of Concentration of Recombinant Human Heparan-N-Sulfatase (rhHNS) in Human Cerebrospinal Fluid Using a Ligand Binding Assay |
Instantly find 20 buyers from Medpace
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction